Cana's contract manufacturing orderbook exceeds 25 million units across partners and nine therapeutic categories, with contracts up to 10 years; the division targets over $10 million in recurring gross profit at full capacity.
Cana's contract manufacturing orderbook exceeds 25 million units across partners and nine therapeutic categories, with contracts up to 10 years; the division targets over $10 million in recurring gross profit at full capacity.